Navigation Links
Free Diabetes Health Program Saturday, Oct. 30 at Jefferson State Community College
Date:10/27/2010

BIRMINGHAM, Ala., Oct. 27 /PRNewswire/ -- The Institute for Health Protection (IHP), in partnership with Roche Diabetes Care, the makers of ACCU-CHEK® products and services, and Jefferson State Community College, will host a free community diabetes program at JSCC's Shelby-Hoover campus this Saturday, Oct. 30 from 9 a.m. to 2 p.m. To register for the event, please call (917) 210-2466 or e-mail JianiY@IHPonline.net.

The program will focus on education, prevention and management of Type 2 diabetes. Highlights of the day's event include free diabetes and health screenings, healthcare specialist consultations and a complimentary lunch for all program participants. A panel of prominent local healthcare providers and community leaders, including Alabama State Rep. Mary Sue McClurkin, will be presenting valuable and relevant educational information as well as leading an interactive Q&A session for participants.What:Free Diabetes Health and Screening ProgramWho:Institute for Health ProtectionRoche Diabetes CareJefferson State Community CollegeAlabama State Rep. Mary Sue McClurkinVarious health and community leadersWhen:Saturday, Oct. 30, 2010Time:9 a.m.-2 p.m. (doors open at 8:30 a.m.)Where:Jefferson State Community CollegeShelby-Hoover Campus4600 Valleydale RoadBirmingham, Ala. 35242This event in Birmingham is part of a series of programs focusing on diabetes awareness and prevention that IHP and Roche Diabetes Care have been conducting nation-wide. The overall goal for these programs is to provide educational information for those at-risk for developing diabetes as well as those who have been diagnosed with diabetes.

IHP is a national organization specializing in translating evidence-based healthcare knowledge into everyday practice and patient-centric care. Through partnerships with key stakeholders, from state government officials to local universities, IHP has been able to develop and execute effective and meaningful educational programs for improving the health status of diverse communities. For more information about IHP, please visit www.ihponline.net

Contact: Jiani Yujianiy@ihponline.net(917) 210-2466
'/>"/>

SOURCE Institute for Health Protection
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
5. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
9. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
10. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  A new study ... that the use of opioid therapy to treat chronic ... the likelihood of more harmful consequences, including death. ... M.D., and Zankhana Mehta , M.D., authored the ... on chronic opioid therapy. The study was published in ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
(Date:12/8/2016)... 2016 Mederi Therapeutics Inc . hat die behördliche Zulassung ... für gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast ... of Endoscopy at Wuhan Union Hospital ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Jefferson County, is announcing the launch of a ... Birmingham. , The number of homeless women and children in Birmingham has grown ...
(Date:12/8/2016)... ... 08, 2016 , ... Coffey Agencies, a locally owned and ... in the northern Alabama and Georgia regions, is embarking on a charity drive ... has built a network of support and education facilities to develop and provide ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA ... most comprehensive mental health systems reform legislation in more than fifty years. We ... the commitment of our elected officials to improving mental health services and supports ...
(Date:12/7/2016)... LAKE CITY, UTAH (PRWEB) , ... December 07, ... ... productivity, today announced the release of Smart Device Remote Control through a new ... management across all platforms and strengthens its mobile solutions to help businesses maximize ...
Breaking Medicine News(10 mins):